NCT00987467View on ClinicalTrials.gov

Long-term Topical Cyclosporine for Atopic Keratoconjunctivitis

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Atopic Keratoconjunctivitis
Interventions
DRUG

Cyclosporin 0.05% ophthalmic

Cyclosporine 0.05% ophthalmic solution, 1 drop 6 times in both eyes daily for first month, then 1 drop 4 times in both eyes daily for next month, then dosage was adjusted based on clinical disease by investigator.

Trial Locations (1)

21287

Johns Hopkins Hospital - Wilmer Eye Institute, Baltimore

All Listed Sponsors
lead

Johns Hopkins University

OTHER

NCT00987467 - Long-term Topical Cyclosporine for Atopic Keratoconjunctivitis | Biotech Hunter | Biotech Hunter